NCT03451370 2026-04-15
COBRA
Istituto Oncologico Veneto IRCCS
Active not recruiting
Clinical Trials
49 trialsNCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT05287464 2025-11-26
International Multicentric Study ARON-1
Hospital of Macerata
Recruiting
NCT05197504 2025-09-05
HCC
CHA University
Completed
NCT02420509 2025-06-04
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
University of California, San Diego
Terminated
NCT05525858 2025-04-27
KOSMOSII
Seoul National University Bundang Hospital
Recruiting
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT06858956 2025-03-05
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06849362 2025-02-27
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
Central South University
Enrolling by invitation
NCT06827353 2025-02-14
OVNI-B
Centre Hospitalier Universitaire de NÄ«mes
Recruiting
NCT06682247 2024-11-12
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
Sun Yat-sen University
Not yet recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT06447727 2024-06-07
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Zhongda Hospital
Recruiting
NCT05685836 2024-03-20
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Leiden University Medical Center
Unknown
NCT05173298 2024-02-07
HCC
CHA University
Unknown
NCT06199297 2024-01-26
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT03647592 2023-12-27
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05354674 2023-07-13
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
Fudan University
Not yet recruiting
NCT05869097 2023-05-22
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Hunan Cancer Hospital
Completed
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT01745757 2023-01-27
COMET
UNICANCER
Completed
NCT02843230 2022-04-08
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
Completed
NCT05177666 2022-01-04
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
The University of Hong Kong-Shenzhen Hospital
Unknown
NCT04831528 2021-04-05
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Fudan University
Not yet recruiting
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04213222 2020-08-11
ROBOT
Peking University People's Hospital
Unknown
NCT04397601 2020-05-21
ARBITRATION
National Cancer Institute, Naples
Unknown
NCT02745691 2019-12-13
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
Completed
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03367182 2019-01-11
REBECA
Yonsei University
Completed
NCT02623621 2017-12-07
CIRCUS
Azienda Ospedaliero, Universitaria Pisana
Completed
NCT00537173 2017-01-25
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Hoosier Cancer Research Network
Terminated
NCT02842294 2016-07-22
COBEQOL
Centre Hospitalier Universitaire de Besancon
Unknown
NCT01832415 2016-03-17
ENCOURAGE
ARCAGY/ GINECO GROUP
Completed
NCT00740168 2016-01-21
BevaRet
Technische Universität Dresden
Completed
NCT01860144 2015-05-19
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Peking University
Unknown
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT00674011 2014-05-06
Hypertension in Breast Cancer Patients Receiving Bevacizumab
Dana-Farber Cancer Institute
Terminated
NCT01912443 2014-04-28
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer
Sun Yat-sen University
Unknown
NCT01533740 2014-02-04
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
University of Rome Tor Vergata
Completed
NCT01891708 2013-07-03
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Huazhong University of Science and Technology
Unknown
NCT01814163 2013-03-19
ANGIOMET
Spanish Lung Cancer Group
Completed
NCT00661154 2012-08-10
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
Stanford University
Completed
NCT01652560 2012-07-30
BIBC
Xijing Hospital
Unknown
NCT01311050 2011-12-13
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center
Unknown
NCT01437618 2011-09-21
First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana
Completed